메뉴 건너뛰기




Volumn 3, Issue 1, 2013, Pages 1-6

Candida dubliniensis endophthalmitis: Five cases over 15 years

Author keywords

Candida; Candida dubliniensis; Endophthalmitis; Fungal endophthalmitis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; VORICONAZOLE;

EID: 84891399282     PISSN: None     EISSN: 18695760     Source Type: Journal    
DOI: 10.1186/1869-5760-3-66     Document Type: Article
Times cited : (7)

References (18)
  • 1
    • 0001790745 scopus 로고    scopus 로고
    • Emerging fungal pathogens: Evolving challenges to immunocompromised patients
    • In: Scheld WM, Armstrong D, Hughes JM (eds), chap 15. ASM Press, Washington, DC
    • Walsh TJ (1998) Emerging fungal pathogens: evolving challenges to immunocompromised patients. In: Scheld WM, Armstrong D, Hughes JM (eds) Emerging infections 1, chap 15. ASM Press, Washington, DC
    • (1998) Emerging infections 1
    • Walsh, T.J.1
  • 2
    • 0029100965 scopus 로고
    • Candida dubliniensis sp. nov.: Phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals
    • Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC (1995) Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141:1507-1521
    • (1995) Microbiology , vol.141 , pp. 1507-1521
    • Sullivan, D.J.1    Westerneng, T.J.2    Haynes, K.A.3    Bennett, D.E.4    Coleman, D.C.5
  • 4
    • 84976222352 scopus 로고    scopus 로고
    • First case report of Candida dubliniensis endogenous endophthalmitis
    • Presented at the, April 27-May 1, Accessed 15 Sept 2013
    • Sedeek RW, Shah M, Gentile R, Samson CM (2008) First case report of Candida dubliniensis endogenous endophthalmitis. Presented at the ARVO Annual Meeting April 27-May 1. http://files.abstractsonline.com/SUPT/163/1808/SessionPDF/156.pdf. Accessed 15 Sept 2013
    • (2008) ARVO Annual Meeting
    • Sedeek, R.W.1    Shah, M.2    Gentile, R.3    Samson, C.M.4
  • 7
    • 0742269683 scopus 로고    scopus 로고
    • Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans
    • Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, Coleman DC (2004) Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 4:369-376
    • (2004) FEMS Yeast Res , vol.4 , pp. 369-376
    • Sullivan, D.J.1    Moran, G.P.2    Pinjon, E.3    Al-Mosaid, A.4    Stokes, C.5    Vaughan, C.6    Coleman, D.C.7
  • 10
    • 0032977918 scopus 로고    scopus 로고
    • Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation
    • Meis JF, Ruhnke M, De Pauw BE, Odds FC, Siegert W, Verweij PE (1999) Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis 5:150-153
    • (1999) Emerg Infect Dis , vol.5 , pp. 150-153
    • Meis, J.F.1    Ruhnke, M.2    De Pauw, B.E.3    Odds, F.C.4    Siegert, W.5    Verweij, P.E.6
  • 13
    • 0031656419 scopus 로고    scopus 로고
    • Prevalence of Candida dubliniensis isolates in a yeast stock collection
    • Odds FC, Van Nuffel L, Dams G (1998) Prevalence of Candida dubliniensis isolates in a yeast stock collection. J Clin Microbiol 36:2869-2873
    • (1998) J Clin Microbiol , vol.36 , pp. 2869-2873
    • Odds, F.C.1    Van Nuffel, L.2    Dams, G.3
  • 15
    • 0034130746 scopus 로고    scopus 로고
    • Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals
    • Jabra-Rizk MA, Falkler WA Jr, Merz WG, Baqui AAMA, Kelley JI, Meiller TF (2000) Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J Clin Microbiol 38:423-2426
    • (2000) J Clin Microbiol , vol.38 , pp. 423-2426
    • Jabra-Rizk, M.A.1    Falkler Jr., W.A.2    Merz, W.G.3    Baqui, A.A.M.A.4    Kelley, J.I.5    Meiller, T.F.6
  • 17
    • 77953254693 scopus 로고    scopus 로고
    • Mechanisms of antifungal drug resistance in Candida dubliniensis
    • Coleman DC, Moran GP, McManus BA, Sullivan DJ (2010) Mechanisms of antifungal drug resistance in Candida dubliniensis. Future Med 5:935-949
    • (2010) Future Med , vol.5 , pp. 935-949
    • Coleman, D.C.1    Moran, G.P.2    McManus, B.A.3    Sullivan, D.J.4
  • 18
    • 81555220900 scopus 로고    scopus 로고
    • Candida albicans versus Candida dubliniensis: Why is C. albicans more pathogenic?
    • Moran GP, Coleman DC, Sullivan DJ (2012) Candida albicans versus Candida dubliniensis: why is C. albicans more pathogenic? Int J Microbiol 2012:205921
    • (2012) Int J Microbiol , vol.2012 , pp. 205921
    • Moran, G.P.1    Coleman, D.C.2    Sullivan, D.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.